Keros Therapeutics
KROS
KROS
147 hedge funds and large institutions have $2.08B invested in Keros Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 10 closing their positions.
Holders
147
Holders Change
+26
Holders Change %
+21.49%
% of All Funds
2.13%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
37
Increased
57
Reduced
40
Closed
10
Calls
$4.81M
Puts
$2.86M
Net Calls
+$1.95M
Net Calls Change
+$684K
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$19.1M |
| 2 |
B
2
Braidwell
Stamford,
Connecticut
|
$48.8M |
| 3 |
ACM
3
ADAR1 Capital Management
Austin,
Texas
|
$22.4M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$29.8M |
| 5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$8.21M |
